Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | UT8792LA | OT |
taking fluzone during pregnancy with no reported adverse event; Initial information received on 04-Sep-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 34 years old female pregnant patient who was exposed to Influenza USP Trival A-B Subvirion No preservative Vaccine [Fluzone] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The date of last menstrual period was not reported. The estimated due date is 02-May-2026. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy. On 09-Apr-2025, the pregnant patient received a dose 1 of suspect Influenza USP Trival A-B Subvirion No preservative Vaccine Suspension for injection (strength, expiry date: unknown and lot UT8792LA) via intramuscular route in unknown administration site as prophylactic vaccination (immunization) with no reported adverse event (exposure during pregnancy) (latency: same day). Action taken: not applicable. Additionally, at time of reporting, the pregnancy is still ongoing.